Alignment Healthcare (ALHC) Shares Outstanding (Weighted Average) (2020 - 2025)
Alignment Healthcare's Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $198.0 million for Q4 2025.
- For Q4 2025, Shares Outstanding (Weighted Average) rose 3.79% year-over-year to $198.0 million; the TTM value through Dec 2025 reached $198.0 million, up 3.79%, while the annual FY2025 figure was $198.0 million, 3.79% up from the prior year.
- Shares Outstanding (Weighted Average) reached $198.0 million in Q4 2025 per ALHC's latest filing, up from $197.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $198.0 million in Q4 2025 to a low of $154.4 million in Q1 2021.
- Average Shares Outstanding (Weighted Average) over 5 years is $185.6 million, with a median of $186.7 million recorded in 2022.
- Peak YoY movement for Shares Outstanding (Weighted Average): grew 19.58% in 2021, then decreased 0.39% in 2022.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $181.9 million in 2021, then fell by 0.39% to $181.2 million in 2022, then rose by 2.76% to $186.2 million in 2023, then increased by 2.46% to $190.8 million in 2024, then grew by 3.79% to $198.0 million in 2025.
- Per Business Quant, the three most recent readings for ALHC's Shares Outstanding (Weighted Average) are $198.0 million (Q4 2025), $197.0 million (Q3 2025), and $196.0 million (Q2 2025).